ADMA - Company ID 0001368514
The table below shows ADMA BIOLOGICS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $87.63M | $103.15M | $51.35M | $86.52M | $51.09M | $55.92M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $158.43M | $50.00M | $27.42M | $15.51M | $28.58M | $13.24M |
| Inventory | $206.47M | $170.24M | $172.91M | $163.28M | $124.72M | $81.54M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $466.51M |
| $331.41M |
| $257.01M |
| $270.40M |
| $208.73M |
| $153.74M |
| Property, plant & equipment | $65.06M | $54.71M | $53.84M | $58.26M | $50.94M | $41.59M |
| Goodwill | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M |
| Total assets | $624.24M | $488.68M | $329.18M | $348.46M | $276.25M | $207.67M |
| Accounts payable | $22.52M | $20.22M | $15.66M | $13.23M | $12.43M | $11.07M |
| Total current liabilities | $69.54M | $55.54M | $49.81M | $39.27M | $30.38M | $19.95M |
| Long-term debt | $69.33M | - | - | - | - | - |
| Total liabilities | $146.92M | $139.66M | $193.98M | $196.49M | $135.08M | $119.42M |
| Retained earnings | -$161.65M | -$308.58M | -$506.26M | -$478.02M | -$412.11M | -$340.47M |
| Total equity | $477.32M | $349.02M | $135.21M | $151.97M | $141.17M | $88.25M |